Nancy G Sebring

Author PubWeight™ 26.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A better index of body adiposity. Obesity (Silver Spring) 2011 7.53
2 Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008 1.77
3 Loss of control over eating, adiposity, and psychopathology in overweight children. Int J Eat Disord 2002 1.71
4 The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 2006 1.50
5 Determining the waist circumference in african americans which best predicts insulin resistance. Obesity (Silver Spring) 2008 1.44
6 Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in african americans. Obes Res 2004 1.43
7 Low bone mass in premenopausal women with depression. Arch Intern Med 2007 1.38
8 Sex differences in visceral adipose tissue volume among African Americans. Am J Clin Nutr 2002 1.35
9 Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res 2002 1.34
10 Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes 2011 1.32
11 The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab 2009 1.23
12 Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005 1.21
13 Comparison of methods to assess change in children's body composition. Am J Clin Nutr 2004 1.11
14 Adiponectin and leptin in African Americans. Obesity (Silver Spring) 2008 1.01
15 Effects of calcium supplementation on body weight and adiposity in overweight and obese adults: a randomized trial. Ann Intern Med 2009 0.99
16 Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab 2004 0.96